Why the study?
Despite high-resolution structures of the HCN1 channel in cAMP bound and unbound states, the structural mechanism coupling ligand binding to channel gating was unknown.
This study elucidates the structural mechanism by which the HCN domain couples ligand binding to channel gating in pacemaker channels, providing insights into the regulation of spontaneous electrical activity in the heart and brain.
May inform HCN-targeted therapies for arrhythmias; leaves open clinical translation pending human validation.
Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels control spontaneous electrical activity in heart and brain. Binding of cAMP to the cyclic nucleotide-binding domain (CNBD) facilitates channel opening by relieving a tonic inhibition exerted by the CNBD. Despite high resolution structures of the HCN1 channel in the cAMP bound and unbound states, the structural mechanism coupling ligand binding to channel gating is unknown. Here we show that the recently identified helical HCN-domain (HCND) mechanically couples the CNBD and channel voltage sensing domain (VSD), possibly acting as a sliding crank that converts the planar rotational movement of the CNBD into a rotational upward displacement of the VSD. This mode of operation and its impact on channel gating are confirmed by computational and experimental data showing that disruption of critical contacts between the three domains affects cAMP- and voltage-dependent gating in three HCN isoforms.
No takes yet. Share an insight, caveat, or question.
Porro et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: